Secondary Life Sciences Cities Stay The Course In Economic Headwinds
With the threat of a recession looming on the economic horizon coupled with foreboding predictions of funding drops for life sciences companies, emerging geographic markets across the country are in some cases better-positioned than their more established counterparts to weather the pending storm.
Downturns can be particularly dangerous for emerging markets, especially in life sciences, where there’s particularly high risk and long-term investment in larger developments. In late April, Alexandria Real Estate Equities Chairman Joel Marcus talked about a coming “have and have-not” era of biotech favoring established firms and markets.
But the lower barriers to entry and growing talent pools in smaller markets may help insulate them from coming turmoil, especially those that have managed to attract major development players.
Read the full article at: www.bisnow.com
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
